Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective-Reference-Cited by-同舟云学术

Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective

Published:2010-02 Issue:1-2 Volume:13 Page:29-43
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Verheij Marcel,Vens Conchita,van Triest Baukelien

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference216 articles.

1. BiPar Sciences presents interim phase 2 results for PARP inhibitor BSI-201 at San Antonio Breast Cancer Symposium;Anon;Cancer Biol. Ther.,2009

2. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro;Abdollahi;Cancer Res.,2003

3. Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cells;Adams;Chromosoma,2001

4. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers;Adjei;J. Clin. Oncol.,2008

5. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation;Aguilar-Quesada;Curr. Med. Chem.,2007

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2;Cell Death & Disease;2023-08-01

2. Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer;Clinical Cancer Research;2020-12-01

3. De rol van radiotherapie bij de behandeling van kanker;Leerboek oncologie;2020

4. Hydrogen Gas in Cancer Treatment;Frontiers in Oncology;2019-08-06

The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity

;Cancer Management and Research;2019-06